Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension, Eur Respir J, vol.50, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01757586
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, 2018. ,
Five-Year outcomes of patients enrolled in the REVEAL Registry, Chest, vol.148, pp.1043-1054, 2015. ,
Advances in therapeutic interventions for patients with pulmonary arterial hypertension, Circulation, vol.130, pp.2189-2208, 2014. ,
, , 2015.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Respir J, vol.46, pp.903-975, 2015. ,
Treatment of pulmonary arterial hypertension, N Engl J Med, vol.351, pp.1425-1436, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01455600
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives, Eur Respir J, vol.53, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02612658
Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations, Expert Opin Ther Targets, vol.21, pp.181-190, 2017. ,
Genetics and genomics of pulmonary arterial hypertension, Eur Respir J, vol.53, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02137830
Bone Morphogenetic Proteins in Vascular Homeostasis and Disease, Cold Spring Harb Perspect Biol, vol.10, 2018. ,
TGF-beta and the TGF-beta Family: Context-Dependent Roles in Cell and Tissue Physiology, Cold Spring Harb Perspect Biol, vol.8, 2016. ,
Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity, J Biol Chem, vol.285, pp.36645-36655, 2010. ,
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis, Lancet Respir Med, vol.4, pp.129-137, 2016. ,
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects, Hum Mutat, vol.36, pp.1113-1127, 2015. ,
Molecular genetic framework underlying pulmonary arterial hypertension, Nat Rev Cardiol, vol.17, pp.85-95, 2020. ,
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation, Am J Respir Crit Care Med, vol.177, pp.1377-1383, 2008. ,
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension, Eur Respir J, 2016. ,
Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle, Circulation, vol.133, pp.1747-1760, 2016. ,
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation, Am J Respir Crit Care Med, vol.181, pp.851-861, 2010. ,
, Nat Commun, vol.9, p.1416, 2018.
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells, Blood, vol.109, pp.1953-1961, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00376097
, Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug, vol.133, pp.1783-1794, 2016.
Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension, Am J Respir Crit Care Med, vol.201, pp.575-585, 2020. ,
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension, Am J Respir Crit Care Med, vol.199, pp.891-902, 2019. ,
Pulmonary Vascular Complications of Liver Disease 2 Study G. BMP 9/10 in Pulmonary Vascular Complications of Liver Disease, Am J Respir Crit Care Med, 2020. ,
Elevated levels of activin A in clinical and experimental pulmonary hypertension, J Appl Physiol, vol.106, pp.1356-1364, 1985. ,
ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension, Sci Transl Med, vol.12, 2020. ,
Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.178, pp.534-541, 2008. ,
Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension, Chest, vol.139, pp.994-1002, 2011. ,
Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension, Heart, vol.106, pp.467-473, 2020. ,
Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH), Heart Lung Circ, vol.29, pp.337-344, 2020. ,
Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease, Pediatr Cardiol, vol.38, pp.1620-1626, 2017. ,
Key role of the endothelial TGF-beta/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension, PLoS One, vol.9, p.100310, 2014. ,
Elevated levels of plasma transforming growth factor-beta1 in idiopathic and heritable pulmonary arterial hypertension, Int J Cardiol, vol.222, pp.368-374, 2016. ,
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension, Eur Respir J, vol.34, pp.662-668, 2009. ,
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension, Pulm Circ, vol.3, pp.369-380, 2013. ,
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor, Circulation, vol.105, pp.1672-1678, 2002. ,
Signaling molecules in nonfamilial pulmonary hypertension, N Engl J Med, vol.348, pp.500-509, 2003. ,
Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.170, pp.1340-1348, 2004. ,
Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension, Circ Res, vol.96, pp.1053-1063, 2005. ,
Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells, Am J Physiol Lung Cell Mol Physiol, vol.305, pp.312-321, 2013. ,
Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition, Am J Respir Crit Care Med, vol.197, pp.244-260, 2018. ,
Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta, Am J Pathol, vol.144, pp.286-295, 1994. ,
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension, Circulation, vol.129, pp.1586-1597, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02578269
GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells, Respir Res, vol.12, p.62, 2011. ,
Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension, Arterioscler Thromb Vasc Biol, vol.40, pp.766-782, 2020. ,
URL : https://hal.archives-ouvertes.fr/inserm-02454982
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension, Circ Res, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02007505
Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease, Circulation, vol.119, pp.566-576, 2009. ,
Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline, Am J Pathol, vol.174, pp.380-389, 2009. ,
Sildenefil increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension, Int J Clin Exp Pathol, vol.7, pp.4674-4684, 2014. ,
Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension, Am J Respir Crit Care Med, vol.177, pp.896-905, 2008. ,
Induction of heart valve lesions by small-molecule ALK5 inhibitors, Toxicol Pathol, vol.39, pp.916-924, 2011. ,
Cardiomyocyte SMAD4-Dependent TGF-beta Signaling is Essential to Maintain Adult Heart Homeostasis, JACC Basic Transl Sci, vol.4, pp.41-53, 2019. ,
Ten Dijke P, Rabinovitch M. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension, J Clin Invest, vol.123, pp.3600-3613, 2013. ,
Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension, Eur Respir J, vol.50, 2017. ,
4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats, PLoS One, vol.11, p.157538, 2016. ,
4PBA Restores Signalling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with PAH, Am J Respir Cell Mol Biol, 2020. ,
Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension, Am J Respir Cell Mol Biol, vol.49, pp.403-409, 2013. ,
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension, Nat Med, vol.21, pp.777-785, 2015. ,
Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial, Am J Respir Crit Care Med, vol.199, pp.313-320, 2019. ,
Transforming Growth Factor-beta Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding, J Biol Chem, vol.291, pp.10792-10804, 2016. ,
Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators, Mol Endocrinol, vol.22, pp.2689-2702, 2008. ,
Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex, J Biol Chem, vol.287, pp.27313-27325, 2012. ,
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes, J Clin Invest, vol.130, pp.582-589, 2020. ,
Inhibin alpha-subunit inhibits BMP9-induced osteogenic differentiation through blocking BMP/Smad signal and activating NF-kappaB signal in mesenchymal stem cells, J Cell Biochem, vol.119, pp.8271-8281, 2018. ,
Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway, PLoS One, vol.6, p.25143, 2011. ,
The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice, Am J Physiol Heart Circ Physiol, vol.305, pp.747-755, 2013. ,
Activin A: a mediator governing inflammation, immunity, and repair, Am J Respir Crit Care Med, vol.185, pp.350-352, 2012. ,
Activin a promotes the TGF-beta-induced conversion of CD4+CD25-T cells into Foxp3+ induced regulatory T cells, J Immunol, vol.182, pp.4633-4640, 2009. ,
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B, Cell Commun Signal, vol.13, p.27, 2015. ,
Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells, Hypertension, vol.71, pp.729-741, 2018. ,
Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning, Genes Dev, vol.16, pp.2749-2754, 2002. ,
The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse, Genes Dev, vol.11, pp.1812-1826, 1997. ,
The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice, Dev Biol, vol.213, pp.157-169, 1999. ,
Myostatin negatively regulates satellite cell activation and self-renewal, J Cell Biol, vol.162, pp.1135-1147, 2003. ,
Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy, Mol Ther, vol.22, pp.1423-1433, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02881194
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance, Biochem Biophys Res Commun, vol.337, pp.248-255, 2005. ,
Activin type II receptor signaling in cardiac aging and heart failure, Sci Transl Med, vol.11, 2019. ,
Effects of an ActRIIB.Fc Ligand Trap on Cardiac Function in Simian Immunodeficiency Virus-Infected Male Rhesus Macaques, J Endocr Soc, vol.2, pp.817-831, 2018. ,
Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress, Cardiovasc Res, vol.92, pp.375-384, 2011. ,
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia, Am J Physiol Lung Cell Mol Physiol, vol.287, pp.1241-1247, 2004. ,
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension, Circulation, vol.139, pp.932-948, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02346975
Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia, Arterioscler Thromb Vasc Biol, vol.30, pp.509-517, 2010. ,
Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension, Circulation, vol.118, pp.722-730, 2008. ,
SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension, Hypertension, vol.61, pp.1044-1052, 2013. ,
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions, Am J Physiol Lung Cell Mol Physiol, vol.295, pp.744-755, 2008. ,
Defective pulmonary vascular remodeling in Smad8 mutant mice, Hum Mol Genet, vol.18, pp.2791-2801, 2009. ,
Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension, Am J Physiol Regul Integr Comp Physiol, vol.298, pp.833-842, 2010. ,
Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension, Circ Res, vol.97, pp.496-504, 2005. ,
Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling, J Appl Physiol, vol.100, pp.564-571, 1985. ,
Gremlin plays a key role in the pathogenesis of pulmonary hypertension, Circulation, vol.125, pp.920-930, 2012. ,
Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature, Am J Physiol Lung Cell Mol Physiol, vol.294, pp.98-109, 2008. ,
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice, Circulation, vol.112, pp.553-562, 2005. ,
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation, Circulation, vol.140, pp.1409-1425, 2019. ,
A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels, Eur Respir J, vol.51, 2018. ,
A Selective Transforming Growth Factor-beta Ligand Trap Attenuates Pulmonary Hypertension, Am J Respir Crit Care Med, vol.194, pp.1140-1151, 2016. ,
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension, Circ Res, vol.124, pp.846-855, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02007505
Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice, Am J Pathol, vol.183, pp.1461-1473, 2013. ,
Targeted gene delivery of BMPR2 attenuates pulmonary hypertension, Eur Respir J, vol.39, pp.329-343, 2012. ,
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension, Am J Physiol Lung Cell Mol Physiol, vol.292, pp.1182-1192, 2007. ,
, Alk1 +/-mice Bmpr2 +/-mice carrying a mutant allele lacking exons 4 and 5
, Bmpr2 +/R899X mice Bmpr2 +/?71 and Bmpr2 +/?140 rats Eng +/-mice L1cre + ; Bmpr2 f/f and L1cre + ; Bmpr2 f/+ mice L1Cre + ; Smad1 f/f mice SM22-rtTA x TetO 7 -BMPR2 R899X mice Smad8 lacZ +/? and Smad8 lacZ +/? mice Tagln-Cre +
, Bmpr2, Tgfbr1 (encoding ALK5), Tgfbr2 Perinatal lethality in homozygous KO mice: Acvr2b (encoding ActRIIB), p.3